Quick Answer
PLIANT THERAPEUTICS, INC. reported Shares Outstanding of 61.45 million shares for fiscal year 2025.
PLIANT THERAPEUTICS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 61.45M | +1.0% |
| 2024 | 60.86M | +1.6% |
| 2023 | 59.92M | +22.4% |
| 2022 | 48.94M | +35.6% |
| 2021 | 36.08M | +1.5% |
| 2020 | 35.55M | +1825.9% |
| 2019 | 1.85M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 61.45M | +1.0% | +0.1% |
| June 30, 2025 | 61.39M | +1.6% | +0.0% |
| March 31, 2025 | 61.39M | +1.8% | +0.9% |
| December 31, 2024 | 60.86M | +1.6% | +0.0% |
| September 30, 2024 | 60.85M | +1.6% | +0.7% |
| June 30, 2024 | 60.43M | +2.0% | +0.2% |
| March 31, 2024 | 60.32M | +2.3% | +0.7% |
| December 31, 2023 | 59.92M | +22.4% | +0.1% |
- PLIANT THERAPEUTICS, INC. showed an increase of +1.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, PLIANT THERAPEUTICS, INC.’s shares outstanding has grown by 3228.7% (from 1.85 million shares to 61.45 million shares).
- The most recent figure is from PLIANT THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: